Massachusetts General Hospital is a leading specialty center for electroconvulsive therapy (ECT). Directed by Charles Welch, MD, the Somatic Therapies Service plays an active and important role in the clinical care of many treatment refractory patients.
Staff and their research
Charles Welch MD
Director Somatic Therapies Service
Carlos Fernandez-Robles MD
Attending Psychiatrist Somatic Therapist Service, Psychiatry Oncology Service, Inpatient Psychiatry Consult Service
Cristina Cusin MD
Attending Psychiatrist Somatic Therapist Service, Depression Clinical and Research Program
Clinical Trials
- N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for severe Major Depression
- Comparison of propofol and methoexital anesthesia during ECT in Major Depression Clinical Efficacy and cognitive side effects.
- A Pilot Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy
- Optimal dose of succinylcholine and rocuronium for electroconvulsive treatment
Research
- Retrospective chart review for patients with bipolar disorder who have been treated with electroconvulsive therapy
- Retrospective Chart Review for Child and Adolescent Patients Who Have Been Treated with Electroconvulsive Therapy
Research at Mass General 
Discover the largest hospital-based research program in the U.S. and how clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and bring the latest advances to patient care
Support the Department of Psychiatry
When you support the Department of Psychiatry, you are making a significant contribution to advancing care at the hospital.
